Skip to main content

Table 1 Clinicopathologic parameters of the study subjects

From: PTENgenomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity

 

n=43

Median age (range, years)

63 (47–76)

Median follow-up (months)

62

Median PSA at surgery (ng.ml-1)

8.7

Biochemical recurrence

12 (28%)

Gleason score

 

≤6

13 (30%)

=7

23 (54%)

≥8

7 (16%)

Pathological stage

 

≤T2

27 (63%)

≥T3

16 (37%)